Investor Relations

Delivering value to our shareholders with utmost transparency and timely information.

At Mega Lifesciences public company limited

Investor Relations is responsible for delivering value to our shareholders by communicating all the necessary information on a regular basis.

Investment Highlights

Market leading own consumer health and pharmaceutical brands in fast growing developing markets.

Financial Performance in FY23

Overall operating revenue
THB mn
(Flat YoY)
Gross profit
THB mn
representing 45.2% of operating revenue
SG&A expenses
THB mn
representing 26.7% of operating revenue
Adjusted net profit
THB mn
(up by 1.6% YoY)
Reported net profit
THB mn
(down by 11.0% YoY)

Latest Documents

Read our recent and archived releases, Financial statements, Quarterly results, Presentations, Publications and One Reports.

Financial Statement
Yearly 2023
Yearly 2023
Presentation and Webcast
The 2024 Annual General Meeting of Shareholders
View Webcast
Form 56-1 One Report
Form 56-1 One Report 2023
Resource Center

SET Announcements

17 April 2024
Publication of the Minutes of the 2024 Annual General Meeting of Shareholders on the Company's website
Read More
02 April 2024
Shareholders meeting's resolution
Read More
29 February 2024
Publication of the Invitation to the 2024 Annual General Meeting of Shareholders
Read More

IR Calendar

1Q24 earnings announcement


  • Mr. Manoj Gurbuxani (Primary contact)
  • Mr. Francis Rego
  • Ms. Sujintana Boonworapat
  • Ms. Laila Mitnoi (IR Co-ordinator)
  • Mr. Thomas Abraham
  • Mr. Vivek Dhawan
  • +66 2 769 4230